These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32793236)

  • 1. The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology.
    Mohseni YR; Tung SL; Dudreuilh C; Lechler RI; Fruhwirth GO; Lombardi G
    Front Immunol; 2020; 11():1608. PubMed ID: 32793236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
    Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
    J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building a CAR-Treg: Going from the basic to the luxury model.
    Rosado-Sánchez I; Levings MK
    Cell Immunol; 2020 Dec; 358():104220. PubMed ID: 33096321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cell therapy: Current and future design perspectives.
    Rana J; Biswas M
    Cell Immunol; 2020 Oct; 356():104193. PubMed ID: 32823038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
    De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
    Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function.
    Boroughs AC; Larson RC; Choi BD; Bouffard AA; Riley LS; Schiferle E; Kulkarni AS; Cetrulo CL; Ting D; Blazar BR; Demehri S; Maus MV
    JCI Insight; 2019 Mar; 5(8):. PubMed ID: 30869654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectives.
    Gauthier J; Yakoub-Agha I
    Curr Res Transl Med; 2017 Sep; 65(3):93-102. PubMed ID: 28988742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
    Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion.
    Lamarche C; Ward-Hartstonge K; Mi T; Lin DTS; Huang Q; Brown A; Edwards K; Novakovsky GE; Qi CN; Kobor MS; Zebley CC; Weber EW; Mackall CL; Levings MK
    Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2219086120. PubMed ID: 36972454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells.
    Elahi R; Khosh E; Tahmasebi S; Esmaeilzadeh A
    Front Immunol; 2018; 9():1717. PubMed ID: 30108584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4
    Fu RY; Chen AC; Lyle MJ; Chen CY; Liu CL; Miao CH
    Cell Immunol; 2020 Dec; 358():104216. PubMed ID: 32987195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
    Boardman D; Maher J; Lechler R; Smyth L; Lombardi G
    Biochem Soc Trans; 2016 Apr; 44(2):342-8. PubMed ID: 27068938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets.
    Wu X; Chen PI; Whitener RL; MacDougall MS; Coykendall VMN; Yan H; Kim YB; Harper W; Pathak S; Iliopoulou BP; Hestor A; Saunders DC; Spears E; Sévigny J; Maahs DM; Basina M; Sharp SA; Gloyn AL; Powers AC; Kim SK; Jensen KP; Meyer EH
    Front Immunol; 2024; 15():1415102. PubMed ID: 39007132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells.
    Malviya M; Saoudi A; Bauer J; Fillatreau S; Liblau R
    J Autoimmun; 2020 Mar; 108():102401. PubMed ID: 31948790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.